Centre de Recherches Medicales de Lambar?
- Country
- Gabon
- Type
- Beneficiary
- Website
- www.mru-lambarene.org
- Grants received
- 15
Funding record
- 15 grants on record
- €7,507,905.83 awarded in total
- 2010–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
3 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- ACADEMISCH ZIEKENHUIS LEIDEN
- EBERHARD KARLS UNIVERSITAET TUEBINGEN
- FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA
- BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT
- ABERYSTWYTH UNIVERSITY
- BIOECLOSION SL
Calls from this organisation
No published calls from this organisation.
Grants received
- Appraising the Critical Role of prognostic Biomarkers in the Assessment and Triage of sick African newborns: Advancing a point-of-care device based on sTREM-1 towards CE marking and implementation
- Central Africa Training Platform for Clinical Research on infectious diseases
- Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African children
- PROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AND CLINICAL TESTING OF A NOVEL CAPSID VIRUS LIKE PARTICLE (CVLP) VACCINE
- Innovations for vaccines against helminth infections
- The Integrate study : An adaptive platform trial for the development of a new intervention to combat Lassa fever in Africa
- Pan-Africa network for genomic surveillance of poverty related diseases and emerging pathogens
- Enabling the WHO-Roadmap 2030
- Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival
- Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic: ORCHESTRA
- SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068
- Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842
- Developing and Testing a novel, low-cost, effective HOOKworm VACcine to Control Human Hookworm Infection in endemic countries
- Dissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections: An African-European Research Initiative
- The targeted development of a new generation Vaccine for Schistosomiasis
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.